|
GPN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26580000000087E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.175210E-04 |
| Normal-vs-Stage2 |
2.297700E-03 |
| Normal-vs-Stage3 |
3.808100E-04 |
| Normal-vs-Stage4 |
2.353500E-04 |
| Stage1-vs-Stage2 |
5.627200E-01 |
| Stage1-vs-Stage3 |
7.095200E-01 |
| Stage1-vs-Stage4 |
3.917600E-01 |
| Stage2-vs-Stage3 |
7.945800E-01 |
| Stage2-vs-Stage4 |
8.502800E-01 |
| Stage3-vs-Stage4 |
6.188800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.59540000000247E-05 |
| Normal-vs-AfricanAmerican |
7.951900E-02 |
| Normal-vs-Asian |
3.238800E-03 |
| Caucasian-vs-AfricanAmerican |
4.844000E-01 |
| Caucasian-vs-Asian |
9.421800E-01 |
| AfricanAmerican-vs-Asian |
5.487000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.19200000051556E-07 |
| Normal-vs-Female |
3.183700E-04 |
| Male-vs-Female |
1.431750E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.811400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.398320E-04 |
| Normal-vs-Age(61-80Yrs) |
1.783720E-04 |
| Normal-vs-Age(81-100Yrs) |
7.372100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.878400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.240600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.793400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.941400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.844600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.310800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.383200E-01 |
| Classical-VS-Follicular |
1.899350E-01 |
| Classical-VS-Other |
4.286400E-01 |
| Classical-VS-Normal |
8.822200E-04 |
| Tall-VS-Follicular |
1.589790E-01 |
| Tall-VS-Other |
2.986800E-01 |
| Tall-VS-Normal |
6.774200E-02 |
| Follicular-VS-Other |
8.671400E-01 |
| Follicular-VS-Normal |
2.836500E-04 |
| Other-VS-Normal |
2.369700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51539999999617E-05 |
| Normal-vs-N1 |
2.591800E-04 |
| N0-vs-N1 |
5.430000E-01 |
|
|
